David A Fishman
Overview
Explore the profile of David A Fishman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Momeni M, Kalir T, Farag S, Kinoshita Y, Roman T, Chuang L, et al.
Reprod Sci
. 2014 May;
21(9):1171-6.
PMID: 24784718
Objectives: The accurate distinction of leiomyoma from leiomyosarcoma is essential for patient management. However, the distinction can be difficult to make, particularly in tissue biopsy samples. Immunohistochemistry has been established...
2.
Fleischer A, Lyshchik A, Hirari M, Moore R, Abramson R, Fishman D
J Oncol
. 2012 May;
2012:302858.
PMID: 22619674
Recently, there have been several major technical advances in the sonographic diagnosis of ovarian cancer in its early stages. These include improved assessment of tumor morphology with transvaginal sonography (TVS),...
3.
Dutta S, Wang F, Wu H, Mukherjee T, Fishman D
Gynecol Oncol
. 2011 Jul;
123(1):129-37.
PMID: 21782227
Objectives: Our previous report has implicated the involvement of VEGF-VEGFR-2 h signaling in LPA-induced EOC invasion. However, the mechanism by which LPA regulates VEGF and VEGFR-2 expression remains to be...
4.
Wang F, Fisher J, Fishman D
Gynecol Oncol
. 2010 Nov;
120(2):247-55.
PMID: 21093894
Objectives: MMP-1 is over-expressed in many cancers, with high expression often associated with poor survival. In the present study, we examined the expression of MMP-1 in EOC and its role...
5.
Dutta S, Wang F, Fishman D
Biomark Med
. 2010 Jun;
4(3):437-9.
PMID: 20550476
No abstract available.
6.
Dutta S, Wang F, Phalen A, Fishman D
Cancer Biol Ther
. 2010 Apr;
9(9):668-77.
PMID: 20372062
Despite advances in surgical technologies and the development of more effective chemotherapeutics, epithelial ovarian cancer (EOC) remains the leading cause of death in women with gynecologic malignancies. The high mortality...
7.
Dutta S, Wang F, Fleischer A, Fishman D
AJR Am J Roentgenol
. 2010 Jan;
194(2):349-54.
PMID: 20093595
Objective: The grim ovarian cancer statistics are attributed to the fact that most women typically present with widespread disease at the time of initial diagnosis. Our current diagnostic tools, such...
8.
Fleischer A, Lyshchik A, Andreotti R, Hwang M, Jones 3rd H, Fishman D
AJR Am J Roentgenol
. 2010 Jan;
194(2):343-8.
PMID: 20093594
Objective: The purpose of this article is to discuss and illustrate the use of contrast-enhanced transvaginal sonography for the early detection of ovarian cancer and suggest how this technique may...
9.
Wang F, Ariztia E, Boyd L, Horton F, Smicun Y, Hetherington J, et al.
Gynecol Oncol
. 2010 Jan;
117(1):88-95.
PMID: 20056268
Objectives: Lysophosphatidic acid (LPA) has potent growth-regulatory effect in many cell types and has been linked to the in vivo tumor growth and metastasis in several malignancies. The goal of...
10.
Pua T, Wang F, Fishman D
Future Oncol
. 2009 Dec;
5(10):1659-73.
PMID: 20001802
Lysophosphatidic acid (LPA), a bioactive phospholipid, stimulates survival, proliferation, adhesion, migration and invasion of ovarian cancer cells through the activation of G-protein-coupled plasma membrane receptors. LPA and its receptors are...